BBC News: NHS to save ‘hundreds of millions’ in landmark (Avsatin) drug ruling

21 September 2018
Source: BBC News

A landmark ruling against two leading drug companies could save the NHS “hundreds of millions” a year. Novartis and Bayer were trying to stop NHS doctors from prescribing a cheaper treatment for a serious eye condition. Twelve NHS bodies in the north east of England were offering patients Avastin, a cheaper alternative to the licensed drug, Lucentis. Health bosses said

Read more BBC News: NHS to save ‘hundreds of millions’ in landmark (Avsatin) drug ruling

Guardian: Cheap blindness drug should be made widely available, says WHO

1 June 2016
Source: Guardian

World Health Organisation rejects expensive licensed drug Lucentis to be added to list for all countries in favour of much cheaper Avastin, not yet available in UK. All countries should make available a cheap, unlicensed drug to prevent blindness in older people – one in preference to the expensive licensed version promoted by pharmaceutical companies, a World Health Organisation committee

Read more Guardian: Cheap blindness drug should be made widely available, says WHO